ExecuPharm, a provider of pharmaceutical clinical research support services, has suffered a data security incident that has reportedly been identified as a CLOP ransomware attack, coupled with a corresponding data leak.
Security experts have expressed concern that cybercriminals will target health care organizations at a time when their services may be needed to help respond to the ongoing COVID-19 pandemic. It was already reported last month that the actors behind Maze ransomware were actively extorting Hammersmith Medicines Research (HMR), a UK-based clinical research organization that’s been preparing to play a potential role in testing vaccine candidates for the novel coronavirus.
Now comes an assault against ExecuPharm – a King of Prussia, Penn.-based subsidiary of biopharmaceutical services company Parexel – which provides the pharma industry with such offerings as clinical monitoring, medical monitoring, site contracts and vendor sight. It is unclear to what extent ExecuPharm is providing services that support COVID-19 research efforts.
An official security notification filed by ExecuPharm with the state of Vermont states that on March 13 company files were encrypted and corporate and personnel information was compromised and potentially accessed.
..
Support the originator by clicking the read the rest link below.
